These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31875861)

  • 1. Circulating and Disseminated Tumor Cells in Breast Carcinoma: Report from the Consensus Conference on Tumor Cell Dissemination during the 39th Annual Meeting of the German Society of Senology, Berlin, 27 June 2019.
    Banys-Paluchowski M; Fehm T; Janni W; Solomayer EF; Hartkopf A
    Geburtshilfe Frauenheilkd; 2019 Dec; 79(12):1320-1327. PubMed ID: 31875861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating and Disseminated Tumour Cells in Breast Carcinoma: Report from the Consensus Conference on Tumour Cell Dissemination during the 38th Annual Meeting of the German Society of Senology, Berlin, 14 June 2018.
    Banys-Paluchowski M; Hartkopf A; Meier-Stiegen F; Janni W; Solomayer EF; Fehm T
    Geburtshilfe Frauenheilkd; 2019 Feb; 79(2):177-183. PubMed ID: 30792547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for the presence of tumor cells in bone marrow and peripheral blood in breast cancer patients.
    Cabinakova M; Mikulova V; Malickova K; Vrana D; Pavlista D; Petruzelka L; Zima T; Tesarova P
    Neoplasma; 2015; 62(2):259-68. PubMed ID: 25591591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
    Krishnamurthy S; Cristofanilli M; Singh B; Reuben J; Gao H; Cohen EN; Andreopoulou E; Hall CS; Lodhi A; Jackson S; Lucci A
    Cancer; 2010 Jul; 116(14):3330-7. PubMed ID: 20564098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
    Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
    Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of circulating tumor cells and disseminated tumor cells in primary breast cancer.
    Hayashi N; Yamauchi H
    Breast Cancer; 2012 Apr; 19(2):110-7. PubMed ID: 21643809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current Evidence.
    Banys-Paluchowski M; Krawczyk N; Fehm T
    Front Oncol; 2016; 6():255. PubMed ID: 27990412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
    Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
    Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
    Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
    BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER2-positive DTCs/CTCs in breast cancer.
    Hartkopf AD; Banys M; Fehm T
    Recent Results Cancer Res; 2012; 195():203-15. PubMed ID: 22527508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy.
    Kasimir-Bauer S; Bittner AK; König L; Reiter K; Keller T; Kimmig R; Hoffmann O
    Breast Cancer Res; 2016 Feb; 18(1):20. PubMed ID: 26868521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer.
    Hartkopf AD; Stefanescu D; Wallwiener M; Hahn M; Becker S; Solomayer EF; Fehm TN; Brucker SY; Taran FA
    Breast Cancer Res Treat; 2014 Sep; 147(2):345-51. PubMed ID: 25151295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy in metastatic breast cancer.
    Banys-Paluchowski M; Paluchowski P
    Cancer Drug Resist; 2019; 2(4):1062-1068. PubMed ID: 35582275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients.
    Hartkopf AD; Wallwiener M; Hahn M; Fehm TN; Brucker SY; Taran FA
    Cancer Res Treat; 2016 Jan; 48(1):115-24. PubMed ID: 25687853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients.
    Zhang S; Li L; Wang T; Bian L; Hu H; Xu C; Liu B; Liu Y; Cristofanilli M; Jiang Z
    BMC Cancer; 2016 Jul; 16():526. PubMed ID: 27456503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and Prognostic Relevance of Circulating and Disseminated Tumour Cell in Dogs with Metastatic Mammary Carcinoma: A Pilot Study.
    Marconato L; Facchinetti A; Zanardello C; Rossi E; Vidotto R; Capello K; Melchiotti E; Laganga P; Zamarchi R; Vascellari M
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30717110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
    Lang JE; Hall CS; Singh B; Lucci A
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1463-72. PubMed ID: 17944570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients.
    Wallwiener M; Hartkopf AD; Riethdorf S; Nees J; Sprick MR; Schönfisch B; Taran FA; Heil J; Sohn C; Pantel K; Trumpp A; Schneeweiss A
    BMC Cancer; 2015 May; 15():403. PubMed ID: 25972110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
    Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
    BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.